vs
CVRx, Inc.（CVRX）与Laird Superfood, Inc.（LSF）财务数据对比。点击上方公司名可切换其他公司
CVRx, Inc.的季度营收约是Laird Superfood, Inc.的1.2倍（$16.0M vs $13.3M），Laird Superfood, Inc.净利率更高（-13.2% vs -74.5%，领先61.3%），Laird Superfood, Inc.同比增速更快（15.0% vs 4.4%），过去两年CVRx, Inc.的营收复合增速更高（22.0% vs 16.1%）
CVRx, Inc.是一家处于商业化阶段的医疗科技企业，专注于慢性心血管疾病神经调节疗法的研发与商业化，旗舰产品Barostim系统用于治疗心力衰竭和难治性高血压，核心市场覆盖北美、欧洲，服务对常规药物治疗应答不佳的患者。
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
CVRX vs LSF — 直观对比
营收规模更大
CVRX
是对方的1.2倍
$13.3M
营收增速更快
LSF
高出10.6%
4.4%
净利率更高
LSF
高出61.3%
-74.5%
两年增速更快
CVRX
近两年复合增速
16.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.0M | $13.3M |
| 净利润 | $-11.9M | $-1.8M |
| 毛利率 | 86.3% | 34.1% |
| 营业利润率 | -69.8% | -13.5% |
| 净利率 | -74.5% | -13.2% |
| 营收同比 | 4.4% | 15.0% |
| 净利润同比 | -12.0% | -341.4% |
| 每股收益（稀释后） | $-0.45 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVRXLSF
| Q4 25 | $16.0M | $13.3M | ||
| Q3 25 | $14.7M | $12.9M | ||
| Q2 25 | $13.6M | $12.0M | ||
| Q1 25 | $12.3M | $11.7M | ||
| Q4 24 | $15.3M | $11.6M | ||
| Q3 24 | $13.4M | $11.8M | ||
| Q2 24 | $11.8M | $10.0M | ||
| Q1 24 | $10.8M | $9.9M |
净利润CVRXLSF
| Q4 25 | $-11.9M | $-1.8M | ||
| Q3 25 | $-12.9M | $-975.1K | ||
| Q2 25 | $-14.7M | $-362.2K | ||
| Q1 25 | $-13.8M | $-156.2K | ||
| Q4 24 | $-10.7M | $-398.4K | ||
| Q3 24 | $-13.1M | $-166.1K | ||
| Q2 24 | $-14.0M | $-239.1K | ||
| Q1 24 | $-22.2M | $-1.0M |
毛利率CVRXLSF
| Q4 25 | 86.3% | 34.1% | ||
| Q3 25 | 86.8% | 36.5% | ||
| Q2 25 | 84.3% | 39.9% | ||
| Q1 25 | 83.5% | 41.9% | ||
| Q4 24 | 83.2% | 38.6% | ||
| Q3 24 | 83.2% | 43.0% | ||
| Q2 24 | 83.9% | 41.8% | ||
| Q1 24 | 85.0% | 40.0% |
营业利润率CVRXLSF
| Q4 25 | -69.8% | -13.5% | ||
| Q3 25 | -83.5% | -7.7% | ||
| Q2 25 | -105.8% | -3.3% | ||
| Q1 25 | -108.8% | -1.9% | ||
| Q4 24 | -67.0% | -4.1% | ||
| Q3 24 | -97.3% | -2.3% | ||
| Q2 24 | -118.3% | -3.4% | ||
| Q1 24 | -206.4% | -11.0% |
净利率CVRXLSF
| Q4 25 | -74.5% | -13.2% | ||
| Q3 25 | -87.6% | -7.6% | ||
| Q2 25 | -108.4% | -3.0% | ||
| Q1 25 | -111.5% | -1.3% | ||
| Q4 24 | -69.4% | -3.4% | ||
| Q3 24 | -98.0% | -1.4% | ||
| Q2 24 | -118.8% | -2.4% | ||
| Q1 24 | -206.0% | -10.3% |
每股收益（稀释后）CVRXLSF
| Q4 25 | $-0.45 | — | ||
| Q3 25 | $-0.49 | — | ||
| Q2 25 | $-0.57 | — | ||
| Q1 25 | $-0.53 | — | ||
| Q4 24 | $-0.39 | — | ||
| Q3 24 | $-0.57 | — | ||
| Q2 24 | $-0.65 | — | ||
| Q1 24 | $-1.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $75.7M | $5.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $39.3M | $11.5M |
| 总资产 | $104.8M | $19.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CVRXLSF
| Q4 25 | $75.7M | $5.1M | ||
| Q3 25 | $85.1M | $5.1M | ||
| Q2 25 | $95.0M | $3.9M | ||
| Q1 25 | $102.7M | $7.0M | ||
| Q4 24 | $105.9M | $8.3M | ||
| Q3 24 | $100.2M | $7.9M | ||
| Q2 24 | $70.4M | $7.6M | ||
| Q1 24 | $80.1M | $7.1M |
股东权益CVRXLSF
| Q4 25 | $39.3M | $11.5M | ||
| Q3 25 | $48.1M | $12.8M | ||
| Q2 25 | $57.9M | $13.4M | ||
| Q1 25 | $71.1M | $13.3M | ||
| Q4 24 | $71.1M | $13.2M | ||
| Q3 24 | $65.2M | $13.1M | ||
| Q2 24 | $55.2M | $12.6M | ||
| Q1 24 | $66.3M | $12.7M |
总资产CVRXLSF
| Q4 25 | $104.8M | $19.2M | ||
| Q3 25 | $111.3M | $18.9M | ||
| Q2 25 | $119.6M | $20.4M | ||
| Q1 25 | $129.6M | $21.5M | ||
| Q4 24 | $133.4M | $19.3M | ||
| Q3 24 | $127.7M | $18.8M | ||
| Q2 24 | $96.0M | $18.0M | ||
| Q1 24 | $106.2M | $17.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.8M | $68.4K |
| 自由现金流经营现金流 - 资本支出 | $-9.8M | — |
| 自由现金流率自由现金流/营收 | -61.3% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-40.8M | — |
8季度趋势，按日历期对齐
经营现金流CVRXLSF
| Q4 25 | $-9.8M | $68.4K | ||
| Q3 25 | $-9.7M | $1.2M | ||
| Q2 25 | $-7.9M | $-2.8M | ||
| Q1 25 | $-12.8M | $-1.3M | ||
| Q4 24 | $-8.0M | $339.2K | ||
| Q3 24 | $-10.4M | $305.8K | ||
| Q2 24 | $-9.8M | $642.7K | ||
| Q1 24 | $-10.9M | $-422.3K |
自由现金流CVRXLSF
| Q4 25 | $-9.8M | — | ||
| Q3 25 | $-10.0M | — | ||
| Q2 25 | $-8.0M | — | ||
| Q1 25 | $-12.9M | — | ||
| Q4 24 | $-8.1M | — | ||
| Q3 24 | $-10.4M | — | ||
| Q2 24 | $-10.2M | — | ||
| Q1 24 | $-11.8M | — |
自由现金流率CVRXLSF
| Q4 25 | -61.3% | — | ||
| Q3 25 | -68.1% | — | ||
| Q2 25 | -59.2% | — | ||
| Q1 25 | -104.3% | — | ||
| Q4 24 | -52.5% | — | ||
| Q3 24 | -78.1% | — | ||
| Q2 24 | -86.3% | — | ||
| Q1 24 | -109.7% | — |
资本支出强度CVRXLSF
| Q4 25 | 0.4% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 8.5% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVRX
| US | $14.9M | 93% |
| Other | $1.1M | 7% |
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
